EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 201 filers reported holding EDITAS MEDICINE INC in Q3 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $358,656 | -35.0% | 76,800 | +3.3% | 0.00% | 0.0% |
Q1 2024 | $551,729 | -31.0% | 74,357 | -5.8% | 0.00% | 0.0% |
Q4 2023 | $799,743 | +13.7% | 78,948 | -12.5% | 0.00% | 0.0% |
Q3 2023 | $703,568 | -9.9% | 90,201 | -4.9% | 0.00% | 0.0% |
Q2 2023 | $780,492 | +25.0% | 94,835 | +10.2% | 0.00% | 0.0% |
Q1 2023 | $624,167 | -19.4% | 86,092 | -1.4% | 0.00% | 0.0% |
Q4 2022 | $774,227 | -26.8% | 87,286 | +1.1% | 0.00% | -50.0% |
Q3 2022 | $1,057,000 | +1.9% | 86,344 | -1.5% | 0.00% | 0.0% |
Q2 2022 | $1,037,000 | -37.8% | 87,634 | +0.1% | 0.00% | 0.0% |
Q1 2022 | $1,666,000 | -33.8% | 87,567 | -7.7% | 0.00% | -33.3% |
Q4 2021 | $2,518,000 | -33.7% | 94,852 | +2.6% | 0.00% | -40.0% |
Q3 2021 | $3,798,000 | -28.9% | 92,460 | -1.9% | 0.01% | -28.6% |
Q2 2021 | $5,339,000 | +26.2% | 94,256 | -6.4% | 0.01% | +16.7% |
Q1 2021 | $4,229,000 | -36.5% | 100,696 | +5.9% | 0.01% | -33.3% |
Q4 2020 | $6,665,000 | +149.9% | 95,066 | +0.0% | 0.01% | +125.0% |
Q3 2020 | $2,667,000 | +7.8% | 95,048 | +13.6% | 0.00% | 0.0% |
Q2 2020 | $2,474,000 | +59.7% | 83,634 | +7.1% | 0.00% | +33.3% |
Q1 2020 | $1,549,000 | -33.8% | 78,123 | -1.1% | 0.00% | -25.0% |
Q4 2019 | $2,339,000 | +33.0% | 79,004 | +2.2% | 0.00% | +33.3% |
Q3 2019 | $1,759,000 | -6.9% | 77,333 | +1.2% | 0.00% | -25.0% |
Q2 2019 | $1,890,000 | +9.2% | 76,410 | +8.0% | 0.00% | 0.0% |
Q1 2019 | $1,731,000 | +5.2% | 70,782 | -2.2% | 0.00% | 0.0% |
Q4 2018 | $1,646,000 | -25.9% | 72,356 | +3.6% | 0.00% | 0.0% |
Q3 2018 | $2,222,000 | -11.2% | 69,829 | -0.0% | 0.00% | -20.0% |
Q2 2018 | $2,503,000 | +33.6% | 69,854 | +23.7% | 0.01% | +25.0% |
Q1 2018 | $1,873,000 | +12.3% | 56,489 | +4.1% | 0.00% | +33.3% |
Q4 2017 | $1,668,000 | +28.4% | 54,288 | +0.4% | 0.00% | 0.0% |
Q3 2017 | $1,299,000 | +29.3% | 54,086 | -9.7% | 0.00% | +50.0% |
Q2 2017 | $1,005,000 | +192.2% | 59,900 | +289.0% | 0.00% | +100.0% |
Q1 2017 | $344,000 | +50.2% | 15,400 | +9.2% | 0.00% | – |
Q4 2016 | $229,000 | +16.2% | 14,100 | -3.4% | 0.00% | – |
Q3 2016 | $197,000 | -43.9% | 14,600 | +1.4% | 0.00% | -100.0% |
Q2 2016 | $351,000 | -29.4% | 14,400 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $497,000 | – | 14,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 6,000,000 | $28,020,000 | 0.84% |
Knott David M Jr | 177,000 | $827 | 0.33% |
Integral Health Asset Management, LLC | 675,000 | $3,152,250 | 0.30% |
Avidity Partners Management LP | 816,000 | $3,810,720 | 0.16% |
Green Alpha Advisors, LLC | 30,267 | $141,347 | 0.11% |
PDT Partners, LLC | 246,537 | $1,151,328 | 0.11% |
Spectrum Planning & Advisory Services Inc. | 12,051 | $57,122 | 0.06% |
Woodline Partners LP | 970,491 | $4,532,193 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 168,371 | $786,293 | 0.04% |
Virtus ETF Advisers LLC | 16,489 | $77,004 | 0.04% |